Ashland Inc. · NYSE:ASH

Ashland — Bank of America 2008 Credit Conference

26 slides from Ashland's conference presentation, Nov 21, 2008

  1. Slide 1: Bank of America 2008 Credit Conference

    Bank of America 2008 Credit Conference James J. O'Brien Chairman and Chief Executive Officer November 21, 2008

  2. Slide 2: Forward-Looking Statements

    Forward-Looking Statements This presentation contains forward-looking statements, within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. Such statements include those made with respect to Ashland’s operating performance and Ashland’s a

  3. Slide 3: Agenda

    Agenda • Hercules acquisition • Financial structure • Ashland today • Summary • Questions

  4. Slide 4: Hercules Acquisition: Investment Highlights

    Hercules Acquisition Investment Highlights • Diversified business portfolio serving wide range of end markets • Creates focus and scale in specialty paper chemicals • Leading market positions across platform • Broad geographical diversity - Approximately $3.7 billion of pro forma revenues generated

  5. Slide 5: Hercules Acquisition: Key Terms

    Hercules Acquisition Key Terms • Hercules shareholders receive consideration of: - $18.60 per Hercules share in cash - 0.093 of a share of Ashland stock • Purchase price of $2.6 billion for shares of Hercules stock that were outstanding at the closing date • Net assumed debt of $0.8 billion

  6. Slide 6: Hercules Acquisition: Financing

    Hercules Acquisition Financing • $2.6 billion new financing - Jointly led by Bank of America and Scotia Capital - $2.3 billion drawn at closing • Term Loan A, Term Loan B and bridge loan • $400 million revolver ($100 million drawn) • 10.5 million new common shares issued at closing • $750 million ca

  7. Slide 7: Financing at Close

    Financing at Close 1 Convertible to rollover loan/exchange notes or exchangeable to bonds with not longer than 6-year no-call 4-year provisions. 2 $282MM par. 3 Estimated fair value. 4 Revolver draw = $100MM. (in millions) • Forecasted Year 1 annual book interest expense of approximately $250 millio

  8. Slide 8: Financial Covenants

    Financial Covenants • Consolidated leverage ratio (Consolidated Debt/EBITDA ) - Funding date through Sept. 2009: 3.75x - Dec. 2009 through Sept. 2010: 3.5x - Dec. 2010 through Sept. 2011: 3.0x - Dec. 2011 through Sept. 2012: 2.75x - Dec. 2012 and after: 2.5x • Consolidated fixed charge coverage rati

  9. Slide 9: Synergies: Cost Savings Estimate

    Sales & Marketing Manufacturing Purchasing G&A • $120 million estimate (cost savings only) - Run-rate by the end of FY 2010 - $80 million run-rate by end of FY 2009 Sales & Marketing Manufacturing Purchasing G&A • Estimated one-time integration costs still being finalized • Key areas for synergy - C

  10. Slide 10: Ashland Today

    Ashland Today • Pro forma sales and operating revenue * = $10.7 billion • Pro forma EBITDA * = $717 million • Among top five specialty chemicals companies in North America and top 10 worldwide Ashland Performance Materials Ashland Hercules Water Technologies Ashland Distribution Ashland Consumer Mar

  11. Slide 11: Fiscal 2008 Pro Forma Sales and Operating Revenue

    Ashland Distribution 40% Ashland Consumer Markets 16% 19% North America 65% Latin America/ Other - 4% Europe 24% Fiscal 2008 Pro Forma* Sales and Operating Revenue Ashland Distribution 40% By commercial unit 19% * For the 12 months ended Sept. 30, 2008, including intersegment, Hercules Paper Technol

  12. Slide 12: Corporate Profile

    Ashland Distribution 10% Ashland Performance Materials 13% Ashland Consumer Markets 16% Ashland Hercules Water Technologies 25% Ashland Aqualon Functional Ingredients 36% Corporate Profile * For the 12 months ended Sept. 30, 2008. Ashland Distribution 10% Ashland Performance Materials 13% Ashland He

  13. Slide 13: Focus on Cash Flow

    Focus on Cash Flow • Reduced dividend reflects levels of specialty chemical peers • Capital expenditures expected to be approximately $200 million • Accelerate realization of $120 million of synergies • Focus on expense control and discretionary spending • Other sources

  14. Slide 14: Investment in Ashland

    Investment in Ashland • Focus on cash generation producing results • Realizing cost structure efficiencies • Completion of Hercules acquisition creates a major, global specialty chemicals company - 74 percent of pro forma EBITDA derived from specialty chemicals core, with roughly one-third from bio-

  15. Slide 15: Appendix A: Fiscal 2008 Preliminary Results

    Appendix A Fiscal 2008 Preliminary Results

  16. Slide 16: Fiscal 2008 Preliminary Financial Results

    ) ) ) ) ) ) ) ) ) ) ) ) ) ) Fiscal 2008 Preliminary Financial Results (in millions, except change) Twelve months ended Sept. 30, Fav./(Unfav.) Sales and operating revenue $ 8,381 $ 7,785 8 % Cost of sales 7,056 6,447 (9)% Gross profit 1,325 1,338 (1)% Gross profit percentage 15.8% 17.2% (140) bp Sel

  17. Slide 17: Fiscal 2008 Preliminary Diluted Earnings Per Share

    (in millions) Twelve months ended Sept. 30, 2008 2007 Operating income $ 213 ) $ 216 ) Gain (loss) on MAP Transaction 20 ) (3) Net interest and other financing income 28 ) 46 ) Income from continuing operations before income taxes 261 ) 259 ) Income tax expense 86 ) 58 ) Income from continuing opera

  18. Slide 18: Regulation G: Reconciliation of Operating Income to EBITDA

    Regulation G: Reconciliation of Operating Income to EBITDA The information provided in this presentation regarding earnings before interest, taxes, depreciation, and amortization (EBITDA) does not conform to generally accepted accounting principles (GAAP) and should not be construed as an alternativ

  19. Slide 19: Ashland Inc. Reconciliation of Operating Income to EBITDA

    Ashland Inc. Fiscal Year Ended Sept. 30 Regulation G: Reconciliation of Operating Income to EBITDA (in millions)

  20. Slide 20: Hercules Inc. Reconciliation of Operating Income to EBITDA

    Hercules Inc. 12 Months Ended Sept. 30, 2008 Regulation G: Reconciliation of Operating Income to EBITDA

  21. Slide 21: Appendix B: Commercial Unit Profiles

    Appendix B Commercial Unit Profiles

  22. Slide 22: Ashland Hercules Water Technologies

    North America 43% E&PS 18% Pulp/ Paper 57% Business Overview Customers/ Markets • Pulp and paper processing • Industrial and institutional • Mining • Municipal wastewater treatment • Merchant marine Products/ Services • Process chemicals for microbial and contaminant control, pulping aids and retent

  23. Slide 23: Ashland Performance Materials

    North America 45% Europe 36% Trans- portation 24% Ind. Constr. 27% Res. Constr. 14% Infra- structure 15% Pkg. & Ashland Performance Materials A global leader in specialty chemicals North America 45% Latin America/ Other - 9% Trans- portation 24% Revenue by Geography Revenue by Market For the Fiscal

  24. Slide 24: Ashland Aqualon Functional Ingredients

    Business Overview Customers • Diversified, global customer base Products • Broad product line based on renewable resources - Water soluble polymers (cellulose derivatives and guar) - Pinova products (wood rosin derivatives) Markets • Water-based paints • Paper coatings • Construction • Oilfield (che

  25. Slide 25: Ashland Consumer Markets

    Lubricants 80% Valvoline Int'l - 23% Do-It- Yourself 35% Business Overview Customers • Retail auto parts stores and mass merchandisers who sell to consumers; installers, such as car dealers and quick lubes; distributors Products/ Services • Valvoline® lubricants and automotive chemicals • MaxLife® l

  26. Slide 26: Ashland Distribution

    Chemicals 47% Plastics 41% Construction 24% Other 15% Trans- portation 15% Com- posites 10% Ashland Distribution A leading North American chemicals and plastics distributor Chemicals 47% Environmental Service/Other - 2% Construction 24% Revenue by Product Line Revenue by Market Paint & Coatings - 10

Ashland — Bank of America 2008 Credit Conference on 6ix